TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
VECO

Veeco Instruments Inc

Technology · Semiconductor Equipment & Materials

42.70$ +3.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios VECO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
58.7 7.3 22.4 49.0
3.5 1.7 3.5 1.4 0.6 1.7 1.9 2.6 1.9 2.5 2.3 2.6
1.9 1.1 1.9 0.8 0.8 1.9 2.1 3.5 2.1 2.5 2.1 2.0
2.8 1.2 2.6 1.5 0.8 2.1 2.3 2.8 2.1 2.7 2.5 2.7
31.2 22.1 20.5 15.2 212.8 17.0 34.8
51.9 430.4 66.7 23.2 56.4 14.5 49.4 36.1 37.9
1.9% 0.2% -3.1% 1.5% -14.4% -2.6% 4.3% 1.8% 6.9% 2.0% 2.8% 2.6%
Margins
34.3% 37.2% 40.0% 38.0% 35.7% 37.7% 42.8% 41.5% 40.7% 42.8% 42.4% 40.0%
-20.2% -4.9% -36.2% -13.2% -76.6% -9.4% 5.0% 9.7% 9.3% 10.5% 9.3% 5.4%
-17.0% -6.7% -36.8% -9.2% -75.1% -18.8% -1.8% 4.5% 25.8% -4.6% 10.3% 5.3%
6.7% 0.4% -10.6% 2.0% -9.3% -4.4% 8.0% 4.6% 13.0% 5.1% 6.4% 6.9%
Returns
-9.1% -4.5% -20.6% -5.3% -93.0% -21.0% -2.1% 5.9% 28.9% -4.5% 9.6% 4.0%
-7.2% -3.6% -16.1% -3.2% -45.2% -9.6% -0.9% 2.9% 14.8% -2.5% 5.9% 2.7%
Balance Sheet & Debt
-269 -268 -276 50 79 175 196 114 123 120 134 67
-15.2 4.2 1.4 1.4 14.3 1.3 1.3
79.5% 80.2% 78.4% 60.6% 48.6% 45.8% 45.5% 48.7% 51.2% 54.7% 61.6% 66.8%
0.0 0.0 0.0 0.4 0.7 0.8 0.8 0.5 0.5 0.4 0.4 0.3
Per Share
-1.70 -0.80 -3.11 -1.01 -8.63 -1.66 -0.17 0.49 2.54 -0.56 1.20 0.58
9.98 12.00 8.45 10.97 11.50 8.83 9.39 10.87 9.85 12.39 11.65 10.96
18.78 17.98 15.11 19.03 9.28 7.89 8.44 8.16 8.81 12.51 12.51 14.61
0.67 0.05 -0.90 0.22 -1.07 -0.39 0.75 0.51 1.28 0.63 0.74 0.75

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?